Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Madhusmita Behera

Showing results (61-70 of 89) with videos related to

Pageof 9
Sort By:
Cancer Medicine|May 24, 2022
Impact of concomitant fibrates on immunotherapy outcomes for advanced non-small cell lung cancerWilliam A Stokes, Madhusmita Behera, Renjian Jiang, et al.
The Oncologist|September 25, 2024
The association of azole antifungals with overall survival in patients with non-small cell lung cancer receiving immune checkpoint inhibitorsNikhil T Sebastian, William A Stokes, Madhusmita Behera, et al.
Nature Communications|July 21, 2019
Acetylation regulates ribonucleotide reductase activity and cancer cell growthGuo Chen, Yin Luo, Kurt Warncke, et al.
Cancer Prevention Research (Philadelphia, Pa.)|January 21, 2014
Class I HDACs are mediators of smoke carcinogen-induced stabilization of DNMT1 and serve as promising targets for chemoprevention of lung cancerSeth A Brodie, Ge Li, Adam El-Kommos, et al.
Clinical Lung Cancer|January 4, 2017
Pulmonary Sarcomatoid Carcinoma: An Analysis of the National Cancer Data BaseConor E Steuer, Madhusmita Behera, Yuan Liu, et al.
Clinical Lung Cancer|August 28, 2012
Survival analysis of patients with stage I non-small-cell lung cancer using clinical and DNA repair pathway expression variablesMadhusmita Behera, John J Heine, Gabriel L Sica, et al.
Annals of Surgical Oncology|July 17, 2021
Impact of Metastasectomy and Aggressive Local Therapy in Newly Diagnosed Metastatic Soft Tissue Sarcoma: An Analysis of the NCDBMustafa Abugideiri, James Janopaul-Naylor, Jeffrey Switchenko, et al.
International Journal of Radiation Oncology, Biology, Physics|January 27, 2020
Lung Stereotactic Body Radiation Therapy and Concurrent Immunotherapy: A Multicenter Safety and Toxicity AnalysisSibo Tian, Jeffrey M Switchenko, Zachary S Buchwald, et al.
Cancer|December 24, 2015
Role of race in oncogenic driver prevalence and outcomes in lung adenocarcinoma: Results from the Lung Cancer Mutation ConsortiumConor E Steuer, Madhusmita Behera, Lynne Berry, et al.
The Journal of Clinical Investigation|June 16, 2022
MERTK activation drives osimertinib resistance in EGFR-mutant non-small cell lung cancerDan Yan, Justus M Huelse, Dmitri Kireev, et al.
Pageof 9

Showing results (61-70 of 89) with videos related to

Sort By:
Pageof 9
Cancer Medicine|May 24, 2022
Impact of concomitant fibrates on immunotherapy outcomes for advanced non-small cell lung cancerWilliam A Stokes, Madhusmita Behera, Renjian Jiang, et al.
The Oncologist|September 25, 2024
The association of azole antifungals with overall survival in patients with non-small cell lung cancer receiving immune checkpoint inhibitorsNikhil T Sebastian, William A Stokes, Madhusmita Behera, et al.
Nature Communications|July 21, 2019
Acetylation regulates ribonucleotide reductase activity and cancer cell growthGuo Chen, Yin Luo, Kurt Warncke, et al.
Cancer Prevention Research (Philadelphia, Pa.)|January 21, 2014
Class I HDACs are mediators of smoke carcinogen-induced stabilization of DNMT1 and serve as promising targets for chemoprevention of lung cancerSeth A Brodie, Ge Li, Adam El-Kommos, et al.
Clinical Lung Cancer|January 4, 2017
Pulmonary Sarcomatoid Carcinoma: An Analysis of the National Cancer Data BaseConor E Steuer, Madhusmita Behera, Yuan Liu, et al.
Clinical Lung Cancer|August 28, 2012
Survival analysis of patients with stage I non-small-cell lung cancer using clinical and DNA repair pathway expression variablesMadhusmita Behera, John J Heine, Gabriel L Sica, et al.
Annals of Surgical Oncology|July 17, 2021
Impact of Metastasectomy and Aggressive Local Therapy in Newly Diagnosed Metastatic Soft Tissue Sarcoma: An Analysis of the NCDBMustafa Abugideiri, James Janopaul-Naylor, Jeffrey Switchenko, et al.
International Journal of Radiation Oncology, Biology, Physics|January 27, 2020
Lung Stereotactic Body Radiation Therapy and Concurrent Immunotherapy: A Multicenter Safety and Toxicity AnalysisSibo Tian, Jeffrey M Switchenko, Zachary S Buchwald, et al.
Cancer|December 24, 2015
Role of race in oncogenic driver prevalence and outcomes in lung adenocarcinoma: Results from the Lung Cancer Mutation ConsortiumConor E Steuer, Madhusmita Behera, Lynne Berry, et al.
The Journal of Clinical Investigation|June 16, 2022
MERTK activation drives osimertinib resistance in EGFR-mutant non-small cell lung cancerDan Yan, Justus M Huelse, Dmitri Kireev, et al.
Pageof 9